CV Sciences (CVSI) Non-Current Deferred Tax Liability (2015 - 2026)
CV Sciences' (CVSI) quarterly Non-Current Deferred Tax Liability came in at $7000.0 in Q1 2026, up 75.0% year-on-year from $4000.0 in Q1 2025, and little changed quarter-over-quarter from $7000.0 in Q4 2025.
CV Sciences (CVSI) Non-Current Deferred Tax Liability (2015 - 2026) Analysis & Trends
CV Sciences has disclosed Non-Current Deferred Tax Liability across 12 years of filings, most recently posting $7000.0 for Q1 2026.
- Non-Current Deferred Tax Liability for Q1 2026 came in at $7000.0, up 75.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $7000.0 (up 75.0% YoY), and the FY2025 annual result was $7000.0, up 75.0% from the prior year.
- Non-Current Deferred Tax Liability came in at $7000.0 for Q1 2026 at CV Sciences, roughly flat from $7000.0 in the prior quarter.
- In the past five years, Non-Current Deferred Tax Liability ranged from a high of $240000.0 in Q4 2022 to a low of $4000.0 in Q4 2024.
- The 5-year median for Non-Current Deferred Tax Liability is $11000.0 (2023), against an average of $33235.3.
- Across the five-year window, Non-Current Deferred Tax Liability sank 92.08% in 2023 and jumped 75.0% in 2025, its largest moves.
- CV Sciences' Non-Current Deferred Tax Liability stood at $240000.0 in 2022, then sank by 92.08% to $19000.0 in 2023, then slumped by 78.95% to $4000.0 in 2024, then surged by 75.0% to $7000.0 in 2025, then changed by 0.0% to $7000.0 in 2026.
- The last three Non-Current Deferred Tax Liability figures came in at $7000.0 (Q1 2026), $7000.0 (Q4 2025), and $4000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | CV Sciences | - | - | 1.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7,000.00 |
| Mar 31, 2026 | 7,000.00 |
| Dec 31, 2025 | 7,000.00 |
| Dec 31, 2025 | 7,000.00 |
| Sep 30, 2025 | 4,000.00 |
| Sep 30, 2025 | 4,000.00 |
| Jun 30, 2025 | 4,000.00 |
| Jun 30, 2025 | 4,000.00 |
| Mar 31, 2025 | 4,000.00 |
| Mar 31, 2025 | 4,000.00 |
| Dec 31, 2024 | 4,000.00 |
| Dec 31, 2024 | 4,000.00 |
| Sep 30, 2024 | 19,000.00 |
| Sep 30, 2024 | 19,000.00 |
| Jun 30, 2024 | 19,000.00 |
| Jun 30, 2024 | 19,000.00 |
| Mar 31, 2024 | 19,000.00 |
| Mar 31, 2024 | 19,000.00 |
| Dec 31, 2023 | 19,000.00 |
| Dec 31, 2023 | 19,000.00 |